In several cases, including LRP1B and FOXO1, which are known to act as tumour suppressors in certain cancers, the same signal/polyadenylation signal was disrupted by the same or different mutations in more than one sample (see columns Mut_Recurrence and Signal_Recurrence in Supplementary file 1). This evidence concerns the gene FOXO1 and neoplasm.